Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Neutral
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Protagenic Therapeutics, Inc. Warrant (PTIXW)
Pharmaceutical Preparations
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
149 FIFTH AVENUE, SUITE 500
NEW YORK, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/27/2021
Market Cap
2,400,709
Shares Outstanding
4,330,000
Weighted SO
N/A
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
0.2860
Last Div
0.0000
Range
0.0091-0.0091
Chg
-0.0042
Avg Vol
N/A
Mkt Cap
2400709
Exch
NASDAQ
Country
US
Phone
212 994 8200
DCF Diff
0.2598
DCF
0.2964
Div Yield
0.0000
P/S
809.6928
EV Multiple
-0.2815
P/FV
3.2518
Div Yield %
0.0000
P/E
-0.4024
PEG
0.0104
Payout
0.0000
Current Ratio
2.0293
Quick Ratio
2.0293
Cash Ratio
1.3707
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
-11.6903
Op Margin
-1890.5153
Pretax Margin
-2001.1331
Net Margin
-2001.1331
Eff Tax Rate
-0.0083
ROA
-4.3649
ROE
-2.3837
ROCE
-7.6335
NI/EBT
1.0000
EBT/EBIT
1.0585
EBIT/Rev
-1890.5153
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
-135.0097
CF/Debt
0.0000
Equity Multi
1.8512
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0022
OCF/Share
-1.1233
FCF/Share
-1.1570
Cash/Share
0.2081
OCF/Sales
-1559.7272
FCF/OCF
1.0300
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
-33.3242
Div&CapEx Cov
-33.3242
P/BV
3.2518
P/B
3.2518
P/S
809.6928
P/E
-0.4024
P/FCF
-0.5040
P/OCF
-0.5163
P/CF
-0.5163
PEG
0.0104
P/S
809.6928
EV Multiple
-0.2815
P/FV
3.2518
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | ▼ -480.51K | ▲ 0.00 | ▲ 3.20K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | ▲ 480.51K | ▼ 30.00 | ▲ 26.62K | ▼ 12.57K |
Gross Profit | 0.00 | 0.00 | 0.00 | ▼ -961.02K | ▲ -30.00 | ▼ -23.42K | ▲ -12.57K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | ▲ 2.00 | ▼ 0.00 | ▼ -7.32 | ▲ 0.00 |
Research And Development Expenses | 193.84K | ▲ 516.12K | ▼ 42.06K | ▲ 146.57K | ▲ 257.52K | ▲ 1.01M | ▲ 1.46M |
General And Administrative Expenses | 330.41K | ▼ 221.11K | ▲ 494.82K | ▲ 714.65K | ▼ 398.26K | ▼ 200.80K | ▲ 277.61K |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -26.62K | ▲ -12.57K |
Selling General And Administrative Expenses | 330.41K | ▼ 221.11K | ▲ 494.82K | ▲ 714.65K | ▼ 398.26K | ▼ 174.18K | ▲ 265.04K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -21.00K | ▲ 0.00 |
Operating Expenses | 524.25K | ▲ 737.23K | ▼ 536.88K | ▲ 861.22K | ▼ 655.78K | ▲ 1.19M | ▲ 1.73M |
Cost And Expenses | 524.25K | ▲ 737.23K | ▼ 536.88K | ▲ 861.22K | ▼ 655.78K | ▲ 1.21M | ▲ 1.74M |
Interest Income | 96.00 | ▲ 499.00 | ▼ 8.00 | ▲ 32.64K | ▲ 92.43K | ▼ 53.66K | ▼ 13.87K |
Interest Expense | 96.00 | ▼ -15.39K | ▲ 93.42K | ▼ 59.32K | ▼ 31.96K | ▼ 12.85K | ▼ 0.00 |
Depreciation And Amortization | 85.00 | 85.00 | ▼ 37.00 | ▲ 72.00 | ▼ 30.00 | ▲ 26.62K | ▼ 12.57K |
Ebitda | -258.65K | ▼ -388.79K | ▼ -536.84K | ▼ -828.58K | ▲ -563.35K | ▼ -1.19M | ▼ -1.73M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | ▲ 1.72 | ▼ 0.00 | ▼ -100.00 | ▲ 0.00 |
Operating Income | -524.25K | ▼ -737.23K | ▲ -536.88K | ▼ -861.22K | ▲ -655.78K | ▼ -1.21M | ▼ -1.74M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | ▲ 1.79 | ▼ 0.00 | ▼ -378.82 | ▲ 0.00 |
Total Other Income Expenses Net | -265.51K | ▲ 2.75K | ▲ 106.65K | ▼ -2.49K | ▲ 54.40K | ▼ -463.95K | ▲ 14.07K |
Income Before Tax | -789.66K | ▲ -749.87K | ▲ -523.65K | ▼ -890.39K | ▲ -601.37K | ▼ -1.68M | ▼ -1.72M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | ▲ 1.85 | ▼ 0.00 | ▼ -100.00 | ▲ 0.00 |
Income Tax Expense | 530.83K | ▼ 376.38K | ▼ -106.65K | ▲ -30.15K | ▲ 6.04K | ▼ 2.00 | ▼ -2.00 |
Net Income | -789.66K | ▲ -749.87K | ▲ -523.65K | ▼ -890.39K | ▲ -607.41K | ▼ -1.68M | ▼ -1.72M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | ▲ 1.85 | ▼ 0.00 | ▼ -100.00 | ▲ 0.00 |
Eps | -0.31 | ▲ -0.29 | ▲ -0.20 | ▼ -0.22 | ▲ -0.14 | ▼ -0.38 | ▼ -0.39 |
Eps Diluted | -0.31 | ▲ -0.29 | ▲ -0.20 | ▼ -0.22 | ▲ -0.14 | ▼ -0.38 | ▼ -0.39 |
Weighted Average Shs Out | 2.57M | 2.57M | ▲ 2.57M | ▲ 4.13M | ▲ 4.32M | ▲ 4.38M | ▲ 4.44M |
Weighted Average Shs Out Dil | 2.57M | 2.57M | ▲ 2.57M | ▲ 4.13M | ▲ 4.32M | ▲ 4.38M | ▲ 4.44M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 362.49K | ▲ 798.62K | ▼ 671.09K | ▼ 541.17K | ▼ 215.19K | ▲ 1.29M | ▼ 831.78K |
Short Term Investments | 250.39K | ▼ 0.00 | 0.00 | ▲ 9.83M | ▼ 7.76M | ▼ 2.77M | ▼ 1.59M |
Cash And Short Term Investments | 612.87K | ▲ 798.62K | ▼ 671.09K | ▲ 10.37M | ▼ 7.98M | ▼ 4.06M | ▼ 2.42M |
Net Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 83.40K | ▼ 43.35K | ▲ 208.16K | ▲ 688.67K | ▼ 56.94K | ▲ 144.03K | ▼ 43.99K |
Total Current Assets | 696.27K | ▲ 841.98K | ▲ 879.25K | ▲ 11.06M | ▼ 8.04M | ▼ 4.20M | ▼ 2.47M |
Property Plant Equipment Net | 611.00 | ▼ 296.00 | ▼ 0.00 | 0.00 | ▲ 1.78K | ▲ 123.33K | ▼ 110.76K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.00 | ▲ 0.00 |
Total Non Current Assets | 611.00 | ▼ 296.00 | ▼ 0.00 | 0.00 | ▲ 1.78K | ▲ 123.33K | ▼ 110.76K |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Total Assets | 696.88K | ▲ 842.27K | ▲ 879.25K | ▲ 11.06M | ▼ 8.04M | ▼ 4.32M | ▼ 2.58M |
Account Payables | 52.37K | ▼ 36.16K | ▲ 141.86K | ▲ 278.95K | ▲ 669.70K | ▼ 114.00 | ▲ 108.95K |
Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 344.23K | ▼ 0.00 | 0.00 |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 855.40K | ▲ 1.16M | ▼ 513.33K | ▲ 520.59K | ▼ 105.93K | ▲ 655.14K | ▼ 337.15K |
Total Current Liabilities | 907.77K | ▲ 1.20M | ▼ 655.19K | ▲ 799.54K | ▲ 1.12M | ▼ 655.25K | ▼ 446.10K |
Long Term Debt | 0.00 | ▲ 279.37K | ▲ 1.37M | ▼ 318.43K | ▼ 0.00 | 0.00 | 0.00 |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 52.37K | ▼ 0.00 | 0.00 | 0.00 | ▲ 1.01M | ▼ 0.00 | 0.00 |
Total Non Current Liabilities | 52.37K | ▲ 279.37K | ▲ 1.37M | ▼ 318.43K | ▲ 1.01M | ▼ 0.00 | 0.00 |
Other Liabilities | -52.37K | ▲ 0.00 | 0.00 | 0.00 | ▼ -1.01M | ▲ 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 907.77K | ▲ 1.48M | ▲ 2.03M | ▼ 1.12M | ▲ 1.12M | ▼ 655.25K | ▼ 446.10K |
Preferred Stock | 1.00 | 1.00 | 1.00 | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 1.03K | 1.03K | ▲ 1.04K | ▲ 1.72K | ▼ 434.00 | ▲ 444.00 | 444.00 |
Retained Earnings | -13.40M | ▼ -15.15M | ▼ -17.70M | ▼ -22.22M | ▼ -25.78M | ▼ -30.78M | ▼ -32.50M |
Accumulated Other Comprehensive Income Loss | -170.54K | ▼ -172.36K | ▲ -171.59K | ▼ -248.35K | ▼ -676.91K | ▲ -113.55K | ▲ -86.77K |
Other Total Stockholders Equity | 13.36M | ▲ 14.69M | ▲ 16.72M | ▲ 32.41M | ▲ 33.37M | ▲ 34.56M | ▲ 34.72M |
Total Stockholders Equity | -210.88K | ▼ -634.37K | ▼ -1.15M | ▲ 9.94M | ▼ 6.92M | ▼ 3.67M | ▼ 2.13M |
Total Equity | -210.88K | ▼ -634.37K | ▼ -1.15M | ▲ 9.94M | ▼ 6.92M | ▼ 3.67M | ▼ 2.13M |
Total Liabilities And Stockholders Equity | 696.88K | ▲ 842.27K | ▲ 879.25K | ▲ 11.06M | ▼ 8.04M | ▼ 4.32M | ▼ 2.58M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 696.88K | ▲ 842.27K | ▲ 879.25K | ▲ 11.06M | ▼ 8.04M | ▼ 4.32M | ▼ 2.58M |
Total Investments | 250.39K | ▼ 0.00 | 0.00 | ▲ 9.83M | ▼ 7.76M | ▼ 2.77M | ▼ 1.59M |
Total Debt | 0.00 | ▲ 279.37K | ▲ 1.37M | ▼ 318.43K | ▲ 344.23K | ▼ 0.00 | 0.00 |
Net Debt | -362.49K | ▼ -519.25K | ▲ 702.71K | ▼ -222.74K | ▲ 129.04K | ▼ -1.29M | ▲ -831.78K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -789.66K | ▲ -749.87K | ▲ -523.65K | ▼ -890.39K | ▲ -601.37K | ▼ -1.68M | ▼ -1.72M |
Depreciation And Amortization | 85.00 | 85.00 | ▼ 37.00 | ▲ 427.14K | ▼ 30.00 | ▲ 26.62K | ▼ 12.57K |
Deferred Income Tax | 0.00 | 0.00 | ▼ -112.51K | ▼ -424.65K | ▲ 0.00 | ▼ -219.94K | ▲ 0.00 |
Stock Based Compensation | 261.14K | ▼ -53.01K | ▲ 411.60K | ▼ 218.17K | ▼ 198.69K | ▼ 166.71K | ▼ 161.86K |
Change In Working Capital | -44.86K | ▲ 545.21K | ▼ -147.08K | ▲ 215.80K | ▼ 190.20K | ▼ -176.58K | ▲ -109.13K |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | 98.59K | ▲ 99.54K | ▼ 0.00 | ▲ 340.12K | ▼ -91.60K | ▼ -134.54K | ▼ -209.16K |
Other Working Capital | -143.45K | ▲ 445.67K | ▼ -195.00 | ▼ -124.32K | ▲ 281.80K | ▼ -42.04K | ▼ -109.13K |
Other Non Cash Items | 265.51K | ▼ 108.16K | ▼ 50.73K | ▼ 48.84K | ▼ 31.52K | ▲ 734.94K | ▼ 186.81K |
Net Cash Provided By Operating Activities | -307.79K | ▲ -149.42K | ▼ -320.87K | ▼ -405.09K | ▲ -180.94K | ▼ -1.14M | ▼ -1.66M |
Investments In Property Plant And Equipment | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.81K | ▼ -93.97K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -57.31K | ▲ -2.37K | ▲ 0.00 |
Purchases Of Investments | -374.50K | ▲ 0.00 | 0.00 | ▼ -10.40M | ▲ 69.24K | ▼ -2.75M | ▲ -297.12K |
Sales Maturities Of Investments | 620.00K | ▼ -4.44K | ▲ 0.00 | ▲ 488.43K | ▼ 94.33K | ▲ 5.12M | ▼ 1.50M |
Other Investing Activities | 246.00 | ▼ 0.00 | 0.00 | ▲ 10.39M | ▼ 57.31K | ▼ 2.37K | ▼ 198.00 |
Net Cash Used For Investing Activities | 245.50K | ▼ -4.44K | ▲ 1.22M | ▼ 485.95K | ▼ 161.77K | ▲ 2.28M | ▼ 1.20M |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | ▲ 670.00K | ▼ -1.22M | ▲ 0.00 | 0.00 | ▲ 10.00 | ▼ 0.00 |
Net Cash Used Provided By Financing Activities | 0.00 | ▲ 670.00K | ▼ -1.22M | ▲ 0.00 | 0.00 | ▲ 10.00 | ▼ 0.00 |
Effect Of Forex Changes On Cash | -7.16K | ▲ 657.00 | ▲ 3.39K | ▼ 199.00 | ▲ 76.04K | ▼ 920.00 | ▼ 190.00 |
Net Change In Cash | -69.45K | ▲ 521.24K | ▼ -317.48K | ▲ 81.06K | ▼ 56.87K | ▲ 1.13M | ▼ -456.12K |
Cash At End Of Period | 362.49K | ▲ 798.62K | ▼ 671.09K | ▼ 541.17K | ▼ 215.19K | ▲ 1.29M | ▼ 831.78K |
Cash At Beginning Of Period | 431.93K | ▼ 277.39K | ▲ 988.57K | ▼ 460.12K | ▼ 158.32K | ▼ 153.33K | ▲ 1.29M |
Operating Cash Flow | -307.79K | ▲ -149.42K | ▼ -320.87K | ▼ -405.09K | ▲ -180.94K | ▼ -1.14M | ▼ -1.66M |
Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.81K | ▼ -93.97K | ▲ 0.00 |
Free Cash Flow | -307.79K | ▲ -149.42K | ▼ -320.87K | ▼ -405.09K | ▲ -182.74K | ▼ -1.24M | ▼ -1.66M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)